Press Releases

OAK BROOK, Ill., Aug. 12, 2019 /PRNewswire/ -- Summer break is in full swing, but our oral health requires studious attention all year round. According to the Children's Oral Health Survey, nearly 1 in 2 parents in America is challenged with getting their kids to practice proper oral care. Moms and dads share that two of the most daunting tasks as a caregive

BOSTON, Aug. 12, 2019 /PRNewswire/ -- Linking employees and their family members with qualified  mental health professionals is a critical but often overlooked tool in preventing opioid abuse, according to experts from

VAUGHAN, ON, Aug. 12, 2019 /PRNewswire/ - CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX: TRST, NYSE: CTST) provided an interim update concerning certain recent developments affecting the Company.

ROCKVILLE, Md., Aug. 12, 2019 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing therapeutics and pharmaceutical products in China, U.S., and throughout the world, announces the product launch of EVOMELA® (melphalan for injection) in

SAN FRANCISCO, Aug. 12, 2019 /PRNewswire/ -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage biotechnology company developing transformational treatments for patients with non-alcoholic steatohepatitis (NASH) and other serious metabolic disorders, today provided a business update and reported second quarter 2019 financial results for the period endin

WALTHAM, Mass., Aug. 12, 2019 /PRNewswire/ -- Oncologie, Inc., a clinical-stage biopharmaceutical company developing innovative oncology treatments targeting the tumor microenvironment, today announced that it has entered into a clinical collaboration agreement with Merck (known as MSD outside the US and Canada) to evaluate the comb

BILLERICA, Mass., Aug. 12, 2019 /PRNewswire/ -- Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.04 per share on the Company's common stock. The dividend will be paid on September 20, 2019 to stockholders of record as of

TEL AVIV, Israel, Aug. 12, 2019 /PRNewswire/ -- Following the one month data of the 9th patient, the Data and Safety Monitoring Board (DSMB) reviewed the safety data from Cellect Biotechnology Ltd.'s (Nasdaq: APOP)  ongoing Phase 1/2 clinical study of ApoGraft™, and announced that the DSMB unanimously recommended dose escalation and the continuatio

INCHEON, South Korea, Aug. 12, 2019 /PRNewswire/ -- Samsung BioLogics (SBL) has successfully performed N-1 (3,000L) perfusion with Alternating Tangential Flow (ATF) device to supply the 15,000L commercial production process in the Plant 3 facility at its manufacturing site in Songdo, S. Korea recently, reducing production time by up to 30% for the client.With SBL

STAINES-UPON-THAMES, United Kingdom, Aug. 12, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today confirmed enrollme